Improving the production of heart cells from stem cells for better treatments.
EFFICIENT DIFFERENTIATION, SCALE-UP, AND MATURATION OF IPS DERIVED CARDIOMYOCYTES
This study is working on a better way to grow heart cells from stem cells, which can help doctors understand and treat heart diseases more effectively, making it easier to use these cells in patient care.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Link Biosystems INC. NIH-funded |
| Lab location | 1 site (Irvington, United States) |
| Project ID | NIH-10761485 on NIH RePORTER |
What this research studies
This research focuses on enhancing the production of heart cells derived from induced pluripotent stem cells (iPS-CMs), which are crucial for understanding and treating heart diseases. The project aims to develop a more efficient method using innovative bioreactors that allow for better cell growth and maturation, ultimately leading to higher quality heart cells. By creating a controlled environment for cell culture, the researchers hope to reduce costs and improve the viability of these cells for clinical applications. This approach could make it easier for researchers and healthcare providers to utilize patient-specific heart cells in treatments and studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart diseases who may benefit from innovative cell therapies derived from their own stem cells.
Not a fit: Patients with non-cardiac conditions or those who are not eligible for stem cell therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for heart diseases using advanced cell therapies.
How similar studies have performed: Other research has shown promise in using similar bioreactor technologies for cell production, indicating a potential for success in this approach.
Where this research is happening
Irvington, United States
- Link Biosystems INC. — Irvington, United States (Active)
Researchers
- Principal investigator: Ronaldson, Kacey — Link Biosystems INC.
- Study coordinator: Ronaldson, Kacey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.